
Animal and human data indicate variable effects of interferons in treating coronavirus infections according to inflammatory status and timing of therapy. The study measured plasma levels of 17 cytokines at enrollment. In addition, it tested the treatment effect on 90-day mortality according to cytokine levels and time to treatment using interaction tests. Further work is needed to evaluate whether the inflammatory status assessment can help identify patients with MERS who may benefit from interferon-β1b and lopinavir-ritonavir.
Like
Save
Share